Ignite Creation Date:
2025-12-24 @ 3:52 PM
Ignite Modification Date:
2026-03-08 @ 11:25 PM
Study NCT ID:
NCT05731492
Status:
WITHDRAWN
Last Update Posted:
2025-03-30
First Post:
2023-02-09
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Macitentan in Children Below 2 Years of Age
Sponsor:
Actelion
Organization:
Study Overview
Official Title:
A Multicenter, Open-label, Single-arm Study to Assess the Pharmacokinetics and Safety of Macitentan in Children Aged 1 Month to <2 Years With Pulmonary Arterial Hypertension
Status:
WITHDRAWN
Status Verified Date:
2025-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Sponsor Decision
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to learn what happens to macitentan and its active metabolite (aprocitentan) in the body of children aged between 1 month and 2 years.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?: